Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has enticing clinical potential that has caught the eyes of more than one bull who have sounded off on …

Shares of biopharma Synergy Pharmaceuticals (NASDAQ:SGYP) are now almost half the price one month ago following a controversial equity offering. With prices so …

Roku Inc (NASDAQ:ROKU) had just had quite the earnings party, with investors sending shares skyrocketing November 9th on back of an impressive first …

ACADIA Pharmaceuticals (NASDAQ:ACAD) just yielded a third quarter outclass that has one of the Street’s top analysts impressed in the upshot. What commercial …

Innovative healthcare stock Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has massive upside potential according to financial services firm BTIG, as it takes rare bearish stance …

Valeant Pharmaceuticals (NYSE:VRX) has gotten some of the Street excited after a much-needed third quarter beat to re-ignite confidence after a string of …

Dynavax Technologies (NASDAQ:DVAX) after five years of “torturous” waiting has at long last garnered FDA approval for Heplisav-B. Cowen analyst Phil Nadeau anticipates hundreds of …

The fundamentals behind Omeros’ (NASDAQ:OMER) eye drug Omidria continue to get better, but Cantor analyst Elemer Piros believes the company still needs to remove …

Synergy Pharmaceuticals (NASDAQ:SGYP) stock may be getting some heat in the market today after releasing third quarter results yesterday, yet one bullish voice …

MannKind Corporation (NASDAQ:MNKD) could be ready to capture an enticing amount of diabetes market share despite what the Street mostly dismissed as a …